Journal of Clinical Oncology, 40(11), 1220-1230. American Society of Clinical Oncology Versteijne, E, van Dam, J L, Suker, M, Janssen, Q P, Groothuis, K, Akkermans-Vogelaar, J M, Besselink, M G, Bonsing, B A, Buijsen, J, Busch, O R, Creemers, G-J M, van Dam, R M, Eskens, F A L M, Festen, S, de Groot, J W B, Groot Koerkamp, B, de Hingh, I H, Homs, M Y V, van Hooft, J E, Kerver, E D, Luelmo, S A C, Neelis, K J, Nuyttens, J, Paardekooper, G M R M, Patijn, G A, van der Sangen, M J C, de Vos-Geelen, J, Wilmink, J W, Zwinderman, A H, Punt, C J, van Tienhoven, G & van Eijck, C H J 2022, ' Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer : Long-Term Results of the Dutch Randomized PREOPANC Trial ', Journal of Clinical Oncology, vol. 40, no. 11, pp. 1220-1230 . https://doi.org/10.1200/JCO.21.02233 Journal of Clinical Oncology, 40(11), 1220-+. LIPPINCOTT WILLIAMS & WILKINS Journal of clinical oncology, 40(11), 1220-1230. American Society of Clinical Oncology
Journal of Clinical Oncology, 38(16), 1763-1773. AMER SOC CLINICAL ONCOLOGY Journal of clinical oncology, 38(16), 1763-1773. American Society of Clinical Oncology Journal of Clinical Oncology, 38(16), 1763-1773. American Society of Clinical Oncology J Clin Oncol